Factors affecting eye conservation and metastasis in posterior uveal melanomas

Abstract

Purpose

To determine the effect of patient and tumor features and different treatments on eye removal (enucleation or exenteration) and metastasis in posterior uveal melanoma (PUM).

Methods

Retrospective analysis. Patient age (≤60 vs >60 years), sex (female vs male), visual acuity (VA, ≤20/40 vs >20/40), largest tumor basal diameter (LTBD), tumor thickness, tumor stage according to American Joint Committee on Cancer (AJCC) 8^th edition, ciliary body involvement, distance to optic disc (OD)/fovea (≤3 mm vs >3 mm), OD involvement, and histopathology were evaluated. Primary treatment options were transpupillary thermotherapy, plaque radiotherapy, Cyberknife radiosurgery, exoresection, and eye removal. Risk factors for primary eye removal were determined using logistic regression test and those for secondary eye removal and metastasis with Cox regression analysis.

Results

Of 387 cases, 153 (39.5%) underwent primary eye removal. Multivariable risk factors for primary eye removal included AJCC tumor stage (p = 0.001, OR:4.586; p < 0.001, OR:34.545; p < 0.001, OR:103.468 for stages T2, T3, and T4 vs stage T1, respectively), and VA≤20/40 (p = 0.014, OR:2.597). Multivariable risk factors for secondary eye removal were VA≤20/40 (p = 0.019, RR:2.817) and AJCC stage T3 vs T1 (p = 0.021, RR:2.666). Eye preservation rates in patients undergoing eye-conserving treatments were 80.3%, 69.6%, and 51.5% at 5, 10, and 15 years, respectively. Metastasis-free survival rates were 81.0%, 73.0%, and 56.7% at 5, 10, and 15 years, respectively. Multivariable risk factors for metastasis included eye removal as primary treatment (p = 0.005, RR:2.828) and mixed type histopathology (p < 0.001, RR:4.804).

Discussion

Early diagnosis is crucial for both eye preservation and survival in PUM. Increasing AJCC tumor stage and lower VA were risk factors for eye removal in this study. Mixed type histopathology and primary eye removal were risk factors for metastasis.

Keywords

uveal melanoma enucleation eye preservation plaque radiotherapy cyberknife stereotactic radiosurgery metastasis

Get full access to this article

View all access options for this article.

References

McCormick

, et al. Population-based incidence of uveal melanoma in various races and ethnic groups. Am J Ophthalmol 2005; 140: 612–617.

Kaliki

Shields

. Uveal melanoma: relatively rare but deadly cancer. Eye (Lond) 2017; 31: 241–257.

Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanoma. COMS report no. 5. Arch Ophthalmol 1997; 115: 1537–1544.

Diener-West

Earle

Fine

, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS report no. 18. Arch Ophthalmol 2001; 119: 969–982.

Collaborative Ocular Melanoma Study Group. The collaborative ocular melanoma study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma, II: initial mortality findings. COMS report no. 10. Am J Ophthalmol 1998; 125: 779–796.

Kivela

Simpson

Grossniklaus

, et al. Uveal melanoma. In: Amin

. AJCC Cancer staging manual. 8th ed. Cham: Springer, 2017, 812–813.

Mashayekhi

Shields

Rishi

, et al. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control. Ophthalmology 2015; 122: 600–609.

O’Day

Pejnovic

Isaacs

, et al. Australian and New Zealand study of photodynamic therapy in choroidal amelanotic melanoma. Retina 2020; 40: 972–976.

Mirzayev

Gündüz

Okçu Heper

. Partial lamellar sclerouvectomy surgery for anteriorly located uveal tumour resection: a 20-year experience. Eye (Lond) 2022; 36: 969–977.

10.

Shields

Shah

, et al. Partial lamellar sclerouvectomy for ciliary body and choroidal tumours. Ophthalmology 1991; 98: 971–983.

11.

Gündüz

Mirzayev

. Surgical approach in intraocular tumors. Turk J Ophthalmol 2022; 52: 125–138.

12.

Gündüz

Mirzayev

. Secondary endoresection for previously treated choroidal melanomas with a non-responsive course and persistent exudative retinal detachment. Int J Ophthalmol 2022; 15: 276–283.

13.

Biewald

Lautner

Gök

, et al. Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases. Br J Ophthalmol 2017; 101: 204–208.

14.

Özcan

Gündüz

Mirzayev

, et al. Early results of stereotactic radiosurgery in uveal melanoma and risk factors for radiation retinopathy. Turk J Ophthalmol 2020; 50: 156–162.

15.

Eibl-Lindner

Fürweger

Nentwich

, et al. Robotic radiosurgery for the treatment of medium and large uveal melanoma. Melanoma Res 2016; 26: 51–57.

16.

Gündüz

Shields

, et al. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol 1999; 117: 170–177.

17.

Gündüz

Shields

, et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999; 127: 579–589.

18.

Lane

Kim

Gragoudas

. Long-term risk of melanoma-related mortality for patients with uveal melanoma treated with proton beam therapy. JAMA Ophthalmol 2015; 133: 792–796.

19.

Papakostas

Lane

Morrison

, et al. Long-term outcomes after proton beam irradiation in patients with large choroidal melanomas. JAMA Ophthalmol 2017; 135: 1191–1196.

20.

Verma

Mehta

. Clinical outcomes of proton radiotherapy for uveal melanoma. Clin Oncol (R Coll Radiol) 2016; 28: 17–27.

21.

Böker

Pilger

Cordini

, et al. Neoadjuvant proton beam irradiation vs. adjuvant Ruthenium brachytherapy in transscleral resection of uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2018; 256: 1767–1775.

22.

Reichstein

Karan

. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications. Curr Opin Ophthalmol 2018; 29: 191–198.

23.

Kujala

Mäkitie

Kivelä

. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003; 44: 4651–4659.

24.

Shields

Furuta

Thangappan

, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127: 989–998.

25.

Kaliki

Shields

. Uveal melanoma: estimating prognosis. Indian J Ophthalmol 2015; 63: 93–102.

26.

Damato

Lecuona

. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology 2004; 111: 977–983.

27.

Isager

Ehlers

Urbak

, et al. Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma. Acta Oncol 2006; 45: 285–293.

28.

Rouberol

Roy

Kodjikian

, et al. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years’ experience with beta-rays). Am J Ophthalmol 2004; 137: 893–900.

29.

Bergman

Nilsson

Lundell

, et al. Ruthenium brachytherapy for uveal melanoma, 1979–2003: survival and functional outcomes in the Swedish population. Ophthalmology 2005; 112: 834–840.

30.

King

Awh

Gao

, et al. Iodine-125 episcleral plaque brachytherapy for AJCC T4 posterior uveal melanoma: clinical outcomes in 158 patients. Ocul Oncol Pathol 2019; 5: 340–349.

31.

Jampol

Moy

Murray

, et al. The COMS randomized trial of Iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2020; 127: 148–157.

32.

Puusaari

Jorma Heikkonen

Kivelä

. Ocular complications after iodine brachytherapy for large uveal melanomas. Ophthalmology 2004; 111: 1768–1777.

33.

Sagoo

Shields

Emrich

, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases. JAMA Ophthalmol 2014; 132: 697–702.

34.

Shields

Naseripour

Cater

, et al. Plaque radiotherapy for large posterior uveal melanomas (> or = 8-mm thick) in 354 consecutive patients. Ophthalmology 2002; 109: 1838–1849.

35.

Béliveau-Nadeau

Callejo

Roberge

. Technique for robotic stereotactic irradiation of choroidal melanoma. Cureus 2016; 8: 582.

36.

Yazici

Kiratli

Ozyigit

, et al. Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 2017; 98: 152–158.

37.

Quhill

Salvi

Rennie

, et al. To suture or not to suture? Does globe immobilisation technique affect clinical outcome in stereotactic radiosurgery for uveal melanoma? Br J Neurosurg 2021; 27: 1–4.

38.

McLean

Saraiva

Burnier

Jr.

Pathological and prognostic features of uveal melanomas. Can J Ophthalmol 2004; 39: 343–350.

39.

McLean

Foster

Zimmerman

. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol 1982; 13: 123–132.

40.

Seddon

Polivogianis

Hsieh

, et al. Death from uveal melanoma. Number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol 1987; 105: 801–806.

41.

Mahendraraj

Lau

Lee

, et al. Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7.516 patients from the surveillance, epidemiology, and end results database (1973–2012). Clin Ophthalmol 2016; 10: 2113–2119.

42.

Krohn

Monge

Skorpen

, et al. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation. Eye (Lond) 2008; 22:1398–1403.

43.

Jancar

Budihna

Drnovsek-Olup

, et al. Prognostic factors of choroidal melanoma in Slovenia, 1986–2008. Radiol Oncol 2016; 50: 104–112.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB